MedTrace Logo

Radiological Characterization of Pulmonary Involvement in Patients With Hematological Diseases

NCT06350526 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 148

Last updated 2025-11-24

No results posted yet for this study

Summary

Hematologic malignancies are heterogeneous groups of neoplasia, with frequent pulmonary complications. These complications may be secondary to the patient's comorbidities, to the hemopathy itself, or its treatments. Divided into infectious and non-infectious complications, the etiologies are numerous and varied. This makes the diagnostic approach complex for the clinicians

Conditions

Interventions

DIAGNOSTIC_TEST

Complete Blood Count

blood sample

DIAGNOSTIC_TEST

C-reactive protein

serum sample

DIAGNOSTIC_TEST

O2 saturation

blood sample

DIAGNOSTIC_TEST

Serum ferritin and D-dimer

Blood sample

DIAGNOSTIC_TEST

Liver and renal function tests

Blood sample

DIAGNOSTIC_TEST

Lactate dehydrogenase

Blood sample

DIAGNOSTIC_TEST

coronavirus (SARS-CoV-2) swab

Throat swab

RADIATION

CT chest

Radiation

Sponsors & Collaborators

  • New Valley University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-27
Primary Completion
2025-08-01
Completion
2025-11-21

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06350526 on ClinicalTrials.gov